Investec advised the shareholder of Gelpell AG on the sale to 1Q Health, a portfolio company of NORD Holding
About the deal
Investec acted as the exclusive financial advisor to the shareholder of Gelpell AG in the transaction with 1Q Health, a portfolio company of NORD Holding.
For more than 20 years, the Swiss full-service manufacturer of premium dietary supplements based in Gähwil, Switzerland, supports supplement brands with high-quality capsule production and tailored full-service solutions, from product development to market-ready manufacturing – including softgel, hard, and vegetarian capsules, as well as its proprietary GELPELL® technology for enhanced bioavailability.
1Q Health is a European contract development and manufacturing organization (CDMO) for healthcare products, including medicinal products, food supplements, and functional foods. As a digitally driven CDMO, the group offers solutions along the entire value chain – from product conception and manufacturing to logistics and legally compliant branding and marketing support – and pursues an active buy-and-build strategy to expand its European manufacturing network.
The strategic objective of the partnership is to strengthen 1Q Health’s European CDMO network with new and highly specialized dosage forms and manufacturing capabilities as well as bringing Switzerland into the group’s international footprint. Gelpell will continue to operate as an independent unit within the 1Q Health Group, preserving its established expertise, customer relationships, and Swiss manufacturing identity while benefiting from the group’s broader resources and network. The founder and entrepreneurial team Kristina and Tomas Edvinsson will closely support the further growth of 1Q Health as fellow shareholders, focusing on the Asian market.
Our role
The Investec team advised the owner of Gelpell throughout the entire M&A process until the successful completion of the transaction, including:
- Preparation of business plan and marketing materials,
- Approach of interested parties and realization of a competitive sales process,
- Preparation and management of due diligence,
- Conducting price negotiations,
- Support in negotiations of the legal documentation,
- Coordination of all involved parties, incl. legal and tax advisors.
“”
Investec’s M&A team guided us through the entire selling process of Gelpell with high professionalism, dedication and efficiency. At every stage, we could rely on the team’s strong commitment and reliability. Their clear focus on realizing our objectives and their expertise in the healthcare and CDMO space helped us achieve an excellent transaction outcome with 1Q Health – a strategic partner ideally suited to support Gelpell’s continued successful expansion. Beyond the professional execution, we also greatly appreciated the close personal collaboration with the Investec team.
